Quinn Opportunity Partners’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-133,511
| Closed | -$20.4M | – | 258 |
|
|
2021
Q1 | $20.4M | Buy |
133,511
+36,511
| +38% | +$5.58M | 1.29% | 22 |
|
|
2020
Q4 | $15.2M | Buy |
+97,000
| New | +$15.2M | 1.29% | 17 |
|
|
2017
Q4 | – | Sell |
-1,500
| Closed | -$210K | – | 215 |
|
|
2017
Q3 | $210K | Sell |
1,500
-1,500
| -50% | -$210K | 0.03% | 191 |
|
|
2017
Q2 | $365K | Buy |
+3,000
| New | +$365K | 0.06% | 124 |
|